WO2004061123A3 - Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation - Google Patents
Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation Download PDFInfo
- Publication number
- WO2004061123A3 WO2004061123A3 PCT/US2003/041404 US0341404W WO2004061123A3 WO 2004061123 A3 WO2004061123 A3 WO 2004061123A3 US 0341404 W US0341404 W US 0341404W WO 2004061123 A3 WO2004061123 A3 WO 2004061123A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- methods
- mbcats
- modifiers
- catenin pathway
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003299990A AU2003299990A1 (en) | 2002-12-30 | 2003-12-29 | Mbcats as modifiers of the beta-catenin pathway and methods of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43697402P | 2002-12-30 | 2002-12-30 | |
US60/436,974 | 2002-12-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004061123A2 WO2004061123A2 (fr) | 2004-07-22 |
WO2004061123A3 true WO2004061123A3 (fr) | 2004-12-09 |
Family
ID=32713115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/041404 WO2004061123A2 (fr) | 2002-12-30 | 2003-12-29 | Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003299990A1 (fr) |
WO (1) | WO2004061123A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008107900A2 (fr) * | 2007-03-07 | 2008-09-12 | Yeda Research And Development Co. Ltd. | Compositions et procédés permettant de moduler une migration cellulaire |
-
2003
- 2003-12-29 AU AU2003299990A patent/AU2003299990A1/en not_active Abandoned
- 2003-12-29 WO PCT/US2003/041404 patent/WO2004061123A2/fr not_active Application Discontinuation
Non-Patent Citations (5)
Title |
---|
COX R.T. ET AL: "A Screen for Mutations That Suppress the Phenotype of Drosophila armadillo, the ß-Catenin Homolog", GENETICS, vol. 155, no. 4, August 2000 (2000-08-01), pages 1725 - 1740, XP002981252 * |
LESORT M. ET AL: "Glycogen synthase kinase-3ß, ß-catenin, and tau in postmortem bipolar brain", JOURNAL OF NEURAL TRANSMISSION, vol. 106, no. 11-12, 1999, pages 1217 - 1222, XP002981251 * |
NISHIDA T. ET AL: "Characterization of a Novel Mammalian SUMO-1/Smt3-specific Isopeptidase, a Homologue of Rat Axam, Which Is an Axin-binding Protein Promoting -Catenin Degradation", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 42, 19 October 2001 (2001-10-19), pages 39060 - 39066, XP002981254 * |
NUERNBERGER J. ET AL: "Inversin Forms a Complex with Catenins and N-Cadherin in Polarized Epithelial Cells", MOLECULAR BIOLOGY OF THE CELL, vol. 13, no. 9, September 2002 (2002-09-01), pages 3096 - 3106, XP002981253 * |
WILDING J. ET AL: "Cyclin D1 Is Not an Essential Target of ß-Catenin Signaling During Intestinal Tumorigenesis, but It May Act as a Modifier of Disease Severity in Multiple Intestinal Neoplasia (Min) Mice", CANCER RESEARCH, vol. 62, no. 16, 15 August 2002 (2002-08-15), pages 4562 - 4565, XP002981250 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004061123A2 (fr) | 2004-07-22 |
AU2003299990A8 (en) | 2004-07-29 |
AU2003299990A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003083047A3 (fr) | Genes mp53 en tant que modificateurs de la voie des proteines p53 et methodes d'utilisation | |
WO2002099058A3 (fr) | Kcnmas comme modificateurs de la voie p53 et methodes d'utilisation | |
WO2002099074A3 (fr) | Slc7s utilises en tant que modificateurs de la voie p53 et procedes d'utilisation correspondants | |
WO2005016287A3 (fr) | Prkwnk utilises en tant que modificateurs de la voie rac et methodes d'utilisation associees | |
WO2003051905A3 (fr) | Taojik utilises en tant que modificateurs de la voie beta-catenine et procedes d'utilisation associes | |
WO2002099043A8 (fr) | P5crs identifies comme des modificateurs de la voie p53 et procedes d'utilisation | |
WO2004013309A3 (fr) | Papss comme modificateurs de la voie d'axin et procédés d'utilisation | |
WO2004024882A3 (fr) | Flj20647 utilise en tant que modificateur de la voie p21 et procedes d'utilisation associes | |
EP1438432A4 (fr) | Lrrcaps en tant que modificateurs de la voie de passage p53 et leurs procedes d'utilisation | |
WO2005017121A3 (fr) | Mbcats modificateurs de la voie beta-catenine et methodes d'utilisation | |
WO2004014301A3 (fr) | Genes psmc utilises comme modificateurs du trajet retiniblastome (rb) et techniques d'utilisation | |
WO2003074725A3 (fr) | Mbcat comme modificateurs du mecanisme d'action de la $g(b)-catenine et procedes d'utilisation correspondants | |
WO2004061123A3 (fr) | Mbcat servant de modificateurs de la voie de beta-catenine et leurs procedes d'utilisation | |
WO2004015071A3 (fr) | Genes csnk1gs utilises en tant que modificateurs de la voie p21 et procede d'utilisation associe | |
WO2004048538A3 (fr) | Caseine kinases modifiant la voie rac et leurs procedes d'utilisation | |
WO2004083389A3 (fr) | Genes mbcat utilises comme modificateurs de la voie de la beta-catenine et techniques d'utilisation | |
WO2005017123A3 (fr) | Mptens utilises comme modificateurs de la voie pten et procedes d'utilisation | |
WO2004065542A3 (fr) | Mat2a utilises comme modificateurs de la voie p53 et procedes d'utilisation | |
WO2003052068A3 (fr) | Genes mbcat agissant comme modificateurs du mecanisme d'action de la beta-catenine et methodes d'utilisation | |
WO2004048541A3 (fr) | Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants | |
WO2003074671A3 (fr) | Mbcat tenant lieu de modificateurs de la voie d'une beta-catenine et leurs procedes d'utilisation | |
WO2004047761A3 (fr) | Genes mbcat en tant que modificateurs de la voie beta-catenine et leurs procedes d'utilisation | |
WO2003074673A3 (fr) | Lgals tenant lieu de modificateurs de la voie de chk et leurs procedes d'utilisation | |
WO2003074677A3 (fr) | Mchk comme modulateurs du mecanisme d'action de chk et procedes d'utilisation | |
WO2004083447A3 (fr) | Mbcat en tant que modificateurs de la voie de la beta-catenine et methodes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |